Glycoursodeoxycholic acid CAS NO.64480-66-6
Glycoursodeoxycholic acid CAS NO.64480-66-6

Glycoursodeoxycholic Acid (GUDCA) is a high-purity glycine-conjugated secondary bile acid, the major amidated metabolite of ursodeoxycholic acid (UDCA), isolated as a white to off-white crystalline powder for research use only. This endogenous metabolite is supplied as a reference standard for studying enterohepatic circulation, bile acid pool composition, and the metabolic signaling roles of conjugated bile acids in hepatocytes and intestinal models. It is primarily intended for pharmaceutical R&D scientists, metabolomics researchers, and biochemists investigating lipid metabolism, gut-liver axis signaling, and neuroprotective mechanisms mediated by bile acid receptors.

Ampicillin CAS NO.69-53-4
Ampicillin CAS NO.69-53-4

Ampicillin is a broad-spectrum semi-synthetic β-lactam antibiotic belonging to the aminopenicillin class, widely used in clinical medicine and life science research for its activity against a range of Gram-positive and Gram-negative bacteria. It is a cornerstone antibiotic for treating infections such as respiratory tract infections, meningitis, and endocarditis, and is also commonly employed in microbiology laboratories for selective culturing and antimicrobial susceptibility testing. Its ability to penetrate tissues and inhibit cell wall synthesis makes it a reliable choice for both therapeutic and experimental applications.

Sarafloxacin CAS NO.98105-99-8
Sarafloxacin CAS NO.98105-99-8

Sarafloxacin is a fluoroquinolone antibiotic featuring a broad-spectrum bactericidal action, highly effective against a wide range of veterinary and laboratory bacterial pathogens; it is specifically formulated for research and veterinary applications, offering rapid tissue penetration and prolonged efficacy in animal health studies and microbiological assays.

Bromodiphenhydramine hydrochloride CAS NO.1808-12-4
Bromodiphenhydramine hydrochloride CAS NO.1808-12-4

Bromodiphenhydramine hydrochloride is a high-purity, synthetic ethanolamine derivative supplied as a white to off-white crystalline powder, primarily utilized as a potent antihistamine standard for pharmaceutical R&D and clinical allergy research. This compound is specifically designed for scientists and laboratories investigating H1 receptor antagonism, anticholinergic effects, and the sedative properties of first-generation antihistamines in both in vitro cellular assays and preclinical animal models. It serves as a critical reference material for quality control in the production of allergy relief medications and is essential for researchers studying the pharmacokinetics and pharmacodynamics of brominated diphenhydramine analogs in the treatment of cutaneous allergies and motion sickness.

4-Acetyl-2-methylbenzoic acid CAS NO.55860-35-0
4-Acetyl-2-methylbenzoic acid CAS NO.55860-35-0

4-Acetyl-2-methylbenzoic acid is a high-purity aromatic carboxylic acid derivative, appearing as a white to yellowish crystalline powder, primarily utilized as a versatile organic synthesis building block and a critical pharmaceutical intermediate for advanced chemical manufacturing. Characterized by the presence of both a reactive carboxyl group and an acetyl ketone moiety on a methyl-substituted benzene ring, this compound offers excellent solubility in polar organic solvents such as DMSO, DMF, ethanol, and dichloromethane, while remaining stable under standard storage conditions. It is specifically designed for research scientists, API manufacturers, and agrochemical developers who require a reliable, high-quality precursor to construct complex molecular architectures, including active pharmaceutical ingredients (APIs) and high-performance functional materials.

Broxaldine CAS NO.3684-46-6
Broxaldine CAS NO.3684-46-6
Broxaldine is a synthetic quinoline derivative specifically designed for its remarkable ability to suppress gastric acid secretion, making it an invaluable chemical probe for gastroenterological research and a promising lead compound for developing anti-ulcer drugs that target potassium channels in parietal cells.
Tilmicosin CAS NO.108050-54-0
Tilmicosin CAS NO.108050-54-0

Tilmicosin is a macrolide antibiotic specifically developed for veterinary use, renowned for its exceptional efficacy against respiratory pathogens such as Mycoplasma and Gram-positive bacteria in livestock. It features a unique pharmacokinetic profile that allows for extensive tissue penetration and a long-lasting half-life, making it an ideal choice for the prevention and control of bovine and porcine respiratory diseases. This high-purity powder is designed for easy formulation into feed or water, providing reliable and sustained therapeutic levels to improve animal health and productivity in large-scale farming operations.

7-Acetyltaxol CAS NO.92950-39-5
7-Acetyltaxol CAS NO.92950-39-5

7-Acetyltaxol is a semi-synthetic derivative of paclitaxel, characterized as a white to off-white solid powder primarily utilized as a high-purity reference standard, impurity profiling marker (often identified as Paclitaxel EP Impurity L), and a vital tool for early-stage pharmacological research in oncology. This stable taxane analog features an acetyl group modification at the C-7 position, making it indispensable for researchers conducting structure-activity relationship (SAR) studies, analytical method validation, and the qualitative analysis of paclitaxel-based drug substances. It is specifically catered to pharmaceutical R&D scientists, quality control laboratories, and academic institutions requiring reliable chemical references to ensure drug safety, purity, and compliance with international pharmacopeial standards.

GS-441524 CAS NO.1191237-69-0
GS-441524 CAS NO.1191237-69-0

GS-441524 is a nucleoside analog and the active metabolite of Remdesivir (GS-5734), developed by Gilead Sciences as a broad-spectrum antiviral agent. It is widely recognized as a highly effective treatment for Feline Infectious Peritonitis (FIP), a once-fatal coronavirus disease in cats, and serves as a key pharmaceutical intermediate for antiviral research. The product is typically supplied as a high-purity white to off-white powder for research and development purposes in both medical and veterinary fields.

AST2818mesylate  CAS NO.2130958-55-1
AST2818mesylate CAS NO.2130958-55-1

AST2818 mesylate, also known as Alflutinib or Furmonertinib, is a highly selective third-generation EGFR tyrosine kinase inhibitor (TKI) developed for the targeted treatment of non-small cell lung cancer (NSCLC). It is specifically engineered to potently inhibit EGFR sensitizing mutations (such as exon 19 deletions and L858R) as well as the resistant T790M mutation, while exhibiting minimal off-target effects on wild-type EGFR, thereby offering a favorable safety profile for patients with advanced or metastatic disease.

Ceforanide CAS NO.60925-61-3
Ceforanide CAS NO.60925-61-3

Ceforanide (CAS 60925-61-3) is a high-purity, second-generation cephalosporin antibiotic provided as a reference standard. It is characterized as a parenteral, long-acting cephalosporin with a broad spectrum of activity against Gram-positive and Gram-negative bacteria. Its chemical structure includes an aminothiazolyl moiety and a tetrazole ring, contributing to its enhanced stability against certain β-lactamases. Historically used clinically, it is now primarily utilized in pharmaceutical research as a model compound and a critical standard for quality control.

Cariprazine CAS NO.839712-12-8
Cariprazine CAS NO.839712-12-8

Cariprazine (CAS 839712-12-8) is a high-purity, atypical antipsychotic compound supplied as a reference standard. It is a piperazine derivative functioning as a dopamine D3 and D2 receptor partial agonist with preferential binding affinity for the D3 receptor. Approved by the FDA and EMA, it is clinically indicated for the treatment of schizophrenia, manic or mixed episodes associated with bipolar I disorder, and as an adjunctive therapy for major depressive disorder (MDD), representing a cornerstone in modern neuropsychiatric therapeutics.

Analyzing Oxandrolone Side Effects and Selective Peptides
Jun 13, 26
Analyzing Oxandrolone Side Effects and Selective Peptides
Understanding the nuances of pharmaceutical interactions and potential oxandrolone side effects is critical for researchers and clinicians aiming to optimize patient outcomes in metabolic and cardiovascular studies. While many chemical compounds offer profound therapeutic potential, the ability to distinguish between intended biological activity and adverse reactions ensures a higher standard of safety and efficacy in translational medicine. On a global scale, the demand for high-purity research peptides and active pharmaceutical ingredients has surged as scientific communities seek to mitigate the risks associated with legacy treatments.
Clinical Guide to Oxandrolone Uses and Metabolic Benefits
Jun 12, 26
Clinical Guide to Oxandrolone Uses and Metabolic Benefits
In the contemporary landscape of metabolic medicine and pharmaceutical research, understanding the diverse oxandrolone uses is pivotal for clinicians and researchers alike. While the industry continues to evolve, the demand for high-purity active pharmaceutical ingredients APIs remains the cornerstone of effective therapeutic outcomes, particularly in treating muscle wasting and metabolic dysfunction. The global shift toward personalized medicine has highlighted the importance of specific androgenic agents and GLP-1 agonists in managing complex patient profiles. By analyzing the systemic impact of these compounds, the pharmaceutical sector can better address the needs of patients recovering from severe trauma or managing chronic endocrine imbalances.
Salmon Calcitonin and oxandrolone use for Bone Health
Jun 11, 26
Salmon Calcitonin and oxandrolone use for Bone Health
The global pharmaceutical landscape is increasingly focusing on the precision of bone metabolism regulation, where the strategic oxandrolone use is often discussed in the context of anabolic recovery, yet the specialized application of Salmon Calcitonin provides a critical alternative for systemic calcium management. Understanding the nuanced differences between anabolic agents and calcitonin-based therapies is essential for healthcare providers aiming to treat severe osteoporosis and hypercalcemia. In the realm of chemical raw material manufacturing, the production of high-purity peptides like Salmon Calcitonin represents a pinnacle of biotechnological achievement. While some research focuses on oxandrolone use for muscle wasting, Salmon Calcitonin targets the osteoclast directly,

If you are interested in our products, you can choose to leave your information here, and we will be in touch with you shortly.